The current stock status of KOSPI and KOSDAQ listed pharmaceutical companies over the last six months increased by an average of 7.4%
According to the current stock status of KOSPI and KOSDAQ listed pharmaceutical companies over the last six months, it was increased by an average of 7.4%. 43 of 62 surveyed companies (including holding companies, excluding preferred shares) showed increase in stock, and 19 of 62 companies showed...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
